Results 21 to 30 of about 21,745 (180)

High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris

BMC Cardiovascular Disorders, 2019
Background In-stent restenosis remains an unresolved issue. Inflammation plays a pivotal role in the process of in-stent restenosis. Significant and positive associations were found between red blood cell distribution width (RDW) and inflammation.
Ning Geng, Guangsheng Su, Shaojun Wang, Deling Zou, Wenyue Pang, Yingxian Sun   +5 more
doaj   +1 more source

Viabahn for femoropopliteal in-stent restenosis

Annals of Saudi Medicine, 2012
BACKGROUND AND OBJECTIVES: In-stent restenosis in the femoropopliteal artery is common (20%-40%). Treatment of in-stent restenosis is challenged by poor patency rate.
Owayed Al Shammeri, Fahad Bitar, Jaime Ghitelman, Peter A. Soukas   +3 more
doaj   +1 more source

Paclitaxel eluting stents versus bare metal stents restenosis

Revista Cubana de Medicina Militar, 2021
Introduction: The restenosis of the paclitaxel-eluting stents used in Cuba has not been studied. Objective: To evaluate the restenosis of paclitaxel-eluting stents and conventional stents.
Ronald Aroche Aportela, Adrian Naranjo-Dominguez, Ángel Yaniel Rodríguez Navarro, Alexander Candeaux Martínez, Yaniet Miguel Vázquez, Ángel Gaspar Obregón Santos   +5 more
doaj  

Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis. [PDF]

PLoS ONE, 2016
Carotid artery stenting (CAS) has been advocated as an alternative to redo surgery for the treatment of post-carotid endarterectomy (CEA) stenosis. This study analyzed the efficacy of CAS for post-CEA restenosis, focusing on an analysis of technical and ...
Marine Gaudry, Jean-Michel Bartoli, Laurence Bal, Roch Giorgi, Mariangela De Masi, Pierre-Edouard Magnan, Philippe Piquet   +6 more
doaj   +1 more source

Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis

The Egyptian Heart Journal, 2012
Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry, Islam El-Sherbieny, Enas Swelam   +2 more
doaj   +1 more source

A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts

Bioactive Materials, 2023
Vein grafts are widely used for coronary artery bypass grafting and hemodialysis access, but restenosis remains the ''Achilles' heel'' of these treatments.
Tianshu Chu, Qingye Li, Chun Dai, Xiang Li, Xiang Kong, Yangming Fan, Hongyan Yin, Jianjun Ge   +7 more
doaj   +1 more source

In-Stent Ulceration: An Unusual Pathology

Case Reports in Cardiology, 2014
In-stent restenosis occurs in 10–60% of cases undergoing interventional therapy. Many mechanisms explain the reason for in-stent restenosis, but restenosis due to an ulcerated plaque is very rare and has not been well reported in the literature.
Jagadeesh Kumar Kalavakunta, Shravan Gangula, Vishal Gupta   +2 more
doaj   +1 more source

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents

Российский кардиологический журнал, 2019
Aim. To identify the effect of preprocedural laboratory parameters on the occurrence of in-stent restenosis in various types of stents, to assess the significance of gender, age and various forms of coronary artery disease (CAD) as risk factors for ...
D. V. Shames, A. S. Galyavich, Z. M. Galeeva, L. V. Baleeva   +3 more
doaj   +1 more source

Predictors of Diffuse In-Stent Restenosis, a Retrospective Analysis in a Subset of Egyptian Population

Majalah Kardiologi Indonesia
Background: Despite the fact that DES implantation has decreased theincidence of ISR dramatically, it is not negligible. Diffuse ISR is associated withpoor outcomes.
Ahmed Mahmoud El Amrawy, Mohamed Ibrahim Loutfi, Ahmed Mokhtar Abd El Azeem   +2 more
doaj   +1 more source

Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis

SAGE Open Medical Case Reports, 2021
In recent years, various devices have been approved for peripheral artery disease with femoropopliteal lesions. However, treatment of long, calcified, and diffused lesions is still challenging because these lesions are associated with restenosis.
Naoki Yoshioka, Kensuke Takagi, Takahiro Tokuda, Yasuhiro Morita, Itsuro Morishima   +4 more
doaj   +1 more source